These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1724929)

  • 1. Infantile cortical hyperostosis (Caffey disease): ultrastructural and immunohistochemical characterization of the peritrabecular cells.
    Quacci D; Pazzaglia UE; Dell'Orbo C; Ennas MG
    Histol Histopathol; 1990 Apr; 5(2):187-92. PubMed ID: 1724929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal infantile cortical hyperostosis.
    Pomerance HH; Wallis-Crespo C; Barness EG
    Fetal Pediatr Pathol; 2005; 24(2):89-94. PubMed ID: 16243753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and hormonal mechanisms associated with malignant bone resorption.
    Quinn JM; Matsumura Y; Tarin D; McGee JO; Athanasou NA
    Lab Invest; 1994 Oct; 71(4):465-71. PubMed ID: 7526033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
    Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical characterization of osteoclasts and osteoclast-like cells with monoclonal antibody MB1 on paraffin-embedded tissues.
    Chilosi M; Gilioli E; Lestani M; Menestrina F; Fiore-Donati L
    J Pathol; 1988 Nov; 156(3):251-4. PubMed ID: 2904980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
    O'Keefe RJ; Teot LA; Singh D; Puzas JE; Rosier RN; Hicks DG
    Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infantile cortical hyperostosis. Apropos of 2 cases one with lesions of the metaphyses].
    Alison M; Sterlin M; Poncet J; Michel C; Vinceneux G
    Pediatrie; 1968; 23(3):355-6. PubMed ID: 4920166
    [No Abstract]   [Full Text] [Related]  

  • 11. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment.
    Bugatti S; Caporali R; Manzo A; Vitolo B; Pitzalis C; Montecucco C
    Arthritis Rheum; 2005 Nov; 52(11):3448-59. PubMed ID: 16258900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile cortical hyperostosis. Caffey disease.
    Van Biervliet JP; Hendrickx G; Kramer P
    Acta Paediatr Belg; 1976; 29(3):185-8. PubMed ID: 795262
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infantile cortical hyperostosis (Caffey-Silvermann Syndrome)].
    Hrdinová V; Parizková E
    Stomatol DDR; 1986 Jul; 36(7):396-400. PubMed ID: 3535178
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monostotic variant of infantile cortical hyperostosis (Caffey-Silverman)].
    Bollmann L; Stenger RD
    Zentralbl Chir; 1979; 104(4):240-3. PubMed ID: 375615
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.
    Husheem M; Nyman JK; Vääräniemi J; Vaananen HK; Hentunen TA
    Calcif Tissue Int; 2005 Mar; 76(3):222-30. PubMed ID: 15692727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional osteoclast-like transformation of cultured human myeloma cell lines.
    Calvani N; Cafforio P; Silvestris F; Dammacco F
    Br J Haematol; 2005 Sep; 130(6):926-38. PubMed ID: 16156862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical and ultrastructural studies of cartilage resorption and acid phosphatase activity during antler growth in fallow deer (Dama dama).
    Szuwart T; Kierdorf H; Kierdorf U; Clemen G
    Anat Rec; 2002 Sep; 268(1):66-72. PubMed ID: 12209566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.